Jack Kaye

Business address
C/O Keryx Biopharmaceuticals, 750 Lexington Avenue, New York, NY, 10022
Top holdings (ownership)
QURE and DYAI
Get insider transactions for this reporting owner
Jack Kaye has filed 55 SEC EDGAR filings since 22 Sep 2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 12 Jan 2026 09 Jan 2026 001-36294
144 Open Document Open Filing 09 Jan 2026
4 Open Document Open Filing 4 06 Jan 2026 02 Jan 2026 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 06 Nov 2025 04 Nov 2025 001-36294
144 Open Document Open Filing 04 Nov 2025
4 Open Document Open Filing PRIMARY DOCUMENT 24 Jun 2025 20 Jun 2025 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 13 Jun 2025 11 Jun 2025 001-36294
4 Open Document Open Filing FORM 4 07 Mar 2025 05 Mar 2025 001-32513
4 Open Document Open Filing FORM 4 07 Jan 2025 02 Jan 2025 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 21 Jun 2024 19 Jun 2024 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 17 Jun 2024 13 Jun 2024 001-36294
5 Open Document Open Filing 06 Feb 2024 31 Dec 2023 001-36294
4 Open Document Open Filing FORM 4 04 Jan 2024 02 Jan 2024 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 20 Jun 2023 13 Jun 2023 001-36294
4 Open Document Open Filing FORM 4 SUBMISSION 01 Mar 2023 27 Feb 2023 001-36294
5 Open Document Open Filing FORM 5 05 Jan 2023 31 Dec 2022 001-32513
4 Open Document Open Filing FORM 4 05 Jan 2023 03 Jan 2023 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 17 Jun 2022 15 Jun 2022 001-36294
4 Open Document Open Filing FORM 4 14 Jun 2022 10 Jun 2022 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 02 Mar 2022 28 Feb 2022 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 28 Feb 2022 24 Feb 2022 001-36294
4 Open Document Open Filing FORM 4 05 Jan 2022 03 Jan 2022 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 04 Mar 2021 02 Mar 2021 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 01 Mar 2021 25 Feb 2021 001-36294
4 Open Document Open Filing FORM 4 06 Jan 2021 04 Jan 2021 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT 02 Mar 2020 27 Feb 2020 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 30 Jan 2020 28 Jan 2020 001-36294
4 Open Document Open Filing FORM 4 03 Jan 2020 02 Jan 2020 001-32513
4 Open Document Open Filing FORM 4 27 Jun 2019 25 Jun 2019 001-32513
3 Open Document Open Filing FORM 3 13 Feb 2019 12 Feb 2019 000-55264
4 Open Document Open Filing PRIMARY DOCUMENT 31 Jan 2019 28 Jan 2019 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 31 Jan 2019 25 Jan 2019 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 31 Jan 2018 29 Jan 2018 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT 30 Jan 2018 26 Jan 2018 001-36294
4 Open Document Open Filing FORM 4 31 Jan 2017 27 Jan 2017 001-36294
3 Open Document Open Filing FORM 3 10 Jan 2017 01 Jan 2017 001-36294
4 Open Document Open Filing FORM 4 SUBMISSION 18 Jun 2015 17 Jun 2015 000-30929
4 Open Document Open Filing FORM 4 SUBMISSION 26 Jun 2014 24 Jun 2014 000-30929
4 Open Document Open Filing FORM 4 09 Sep 2013 06 Sep 2013 000-30929
4 Open Document Open Filing FORM 4 21 Jun 2013 19 Jun 2013 000-30929
4 Open Document Open Filing OWNERSHIP DOCUMENT 15 Feb 2013 27 Jun 2012 000-30929
4 Open Document Open Filing OWNERSHIP DOCUMENT 22 Jun 2012 20 Jun 2012 000-30929
4 Open Document Open Filing OWNERSHIP DOCUMENT 04 Jan 2012 03 Jan 2012 000-30929